1. Home
  2. HLI vs CRL Comparison

HLI vs CRL Comparison

Compare HLI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$151.68

Market Cap

10.4B

Sector

Finance

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$160.58

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLI
CRL
Founded
1972
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
8.6B
IPO Year
2015
1999

Fundamental Metrics

Financial Performance
Metric
HLI
CRL
Price
$151.68
$160.58
Analyst Decision
Buy
Buy
Analyst Count
7
12
Target Price
$194.29
$198.27
AVG Volume (30 Days)
671.6K
790.6K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.54%
N/A
EPS Growth
41.61
N/A
EPS
4.74
N/A
Revenue
$2,389,416,000.00
$1,857,601,000.00
Revenue This Year
$13.77
N/A
Revenue Next Year
$12.10
$3.04
P/E Ratio
$31.73
N/A
Revenue Growth
24.81
10.48
52 Week Low
$134.41
$132.58
52 Week High
$211.78
$228.88

Technical Indicators

Market Signals
Indicator
HLI
CRL
Relative Strength Index (RSI) 49.66 45.38
Support Level $146.58 $147.22
Resistance Level $184.59 $166.62
Average True Range (ATR) 4.68 8.97
MACD -0.13 -1.18
Stochastic Oscillator 56.43 31.12

Price Performance

Historical Comparison
HLI
CRL

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: